Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05383_nanopub.RARr5nmovAYPpAd3q7CmmqZ07POFzrjRvpyTqDbMuzwUA#assertion>. }
Showing items 1 to 14 of
14
with 100 items per page.
- drugbank:DB05383 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05383 label "pimagedine HCl [drugbank:DB05383]" assertion.
- drugbank:DB05383 seeAlso DB05383 assertion.
- drugbank:DB05383 identifier "drugbank:DB05383" assertion.
- drugbank:DB05383 description "It has been developed by Synvista Therapeutics, Inc for the treatment of diabetic kidney disease.Pimagedine HCl is an advanced glycation end products inhibitor which manages diabetic nephropathy, either alone or in combination with other therapies. It is beneficial in treating patients with diabetic nephropathy." assertion.
- drugbank:DB05383 title "pimagedine HCl" assertion.
- drugbank:DB05383 bio2rdf_vocabulary:identifier "DB05383" assertion.
- drugbank:DB05383 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05383 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05383" assertion.
- drugbank:DB05383 bio2rdf_vocabulary:x-identifiers.org DB05383 assertion.
- drugbank:DB05383 drugbank_vocabulary:drugbank-id "DB05383" assertion.
- drugbank:DB05383 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05383 drugbank_vocabulary:x-chemspider chemspider:15211 assertion.
- drugbank:DB05383 drugbank_vocabulary:x-pubchemcompound pubchem.compound:16017 assertion.